AIRS Medical Secures Strategic Growth Investment

AIRS Medical Secures Strategic Growth Investment

AIRS Medical, based in Hong Kong and Seoul, a global leader in AI-powered solutions for medical imaging, has announced a strategic growth investment from TA Associates. The funding aims to support the company's global expansion, continued innovation in MRI technology, and ongoing product development.

TA Associates, a leading global private equity firm, served as the investor for this round.

The capital will be used to fuel the next phase of global expansion, accelerate the advancement of AI-powered radiology technology solutions, and support ongoing product innovation for healthcare providers.

Founded in 2018 by Dr. Hyeseong Lee and others, AIRS Medical is an AI-native company focused on transforming medical imaging through deep learning. The company develops MRI acceleration and reconstruction software, including SwiftMR and SwiftSight, which are designed to improve imaging efficiency, increase capacity, and enhance patient access in healthcare settings globally.

Funding Details

Company Website: https://airsmed.com

Company: AIRS Medical

Round: Growth Capital

Funding Date: June 16, 2026

Lead Investor: TA Associates

Software Category: HealthTech / Medical Imaging